ADAM: A Multicenter, Non-Interventional, Prospective Cohort Study for Determination of Prevalence of Homologous Recombination Repair Genes Mutations (hrrm) in Metastatic Castrate-Resistant Prostate Cancer (mcrpc)—interim Analysis.
Journal of clinical oncology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要